Live from the NIH registry
Studies recruiting near Paradise right now
Top 25 of 446 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (6.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
DaVita Clinical Research — Las Vegas, Nevada (6.1 mi)
· Sponsor: R1 Therapeutics
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Las Vegas, Nevada (6.1 mi)
· Sponsor: AstraZeneca
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Las Vegas Clinical Trials — North Las Vegas, Nevada (7.8 mi)
· Sponsor: Crystalys Therapeutics
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada (6.1 mi)
· Sponsor: Eli Lilly and Company
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-072 — Las Vegas, Nevada (6.1 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Optum Care Cancer Center ( Site 9535) — Las Vegas, Nevada (6.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Excel Clinical Research, LLC — Las Vegas, Nevada (6.1 mi)
· Sponsor: Pfizer
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Vector Clinical Trials — Las Vegas, Nevada (6.1 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Las Vegas, Nevada (6.1 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
OptumCare Cancer Care at Charleston — Las Vegas, Nevada (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (6.1 mi)
· Sponsor: NRG Oncology
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
AB Clinical Trials — Las Vegas, Nevada (6.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
UMC of Southern Nevada — Las Vegas, Nevada (6.1 mi)
· Sponsor: Novo Nordisk A/S
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Insomnia Disorder
Phase 3
Interventional 420 participants sought
Vanda Investigational Site — Las Vegas, Nevada (6.1 mi)
· Sponsor: Vanda Pharmaceuticals
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Jubilee Clinical Research, Inc. — Las Vegas, Nevada (6.1 mi)
· Sponsor: Novo Nordisk A/S
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (6.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Metastatic Solid Tumor, Advanced Solid Tumor
Phase 1
Interventional 154 participants sought
Comprehensive Cancer Center of Nevada — Las Vegas, Nevada (6.1 mi)
· Sponsor: Coherus Oncology, Inc.
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 8848 — Las Vegas, Nevada (6.1 mi)
· Sponsor: Galderma R&D
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada (6.1 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Major Depressive Disorder
Phase 4
Interventional 350 participants sought
Clinical Research Site — Las Vegas, Nevada (6.1 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Local Institution - 0121 — North Las Vegas, Nevada (7.8 mi)
· Sponsor: Bristol-Myers Squibb
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada (6.1 mi)
· Sponsor: National Cancer Institute (NCI)